Literature DB >> 23505260

ADCYAP1R1 genotype associates with post-traumatic stress symptoms in highly traumatized African-American females.

Lynn M Almli1, Kristina B Mercer, Kimberly Kerley, Hao Feng, Bekh Bradley, Karen N Conneely, Kerry J Ressler.   

Abstract

Pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptor (PAC1) play a critical role in biological processes that mediate stress response and have been implicated in psychological outcome following trauma. Our previous work [Ressler et al. (2011); Nature 470:492-497] demonstrated that a variant, rs2267735, in the gene encoding PAC1 (ADCYAP1R1) is associated with post-traumatic stress disorder (PTSD) in a primarily African-American cohort of highly traumatized females. We sought to extend and replicate our previous finding in a similarly trauma-exposed, replicate sample of 1,160 African-American adult male and female patients. Self-reported psychiatric measures were collected, and DNA was obtained for genetic analysis. Using linear regression models to test for association with PTSD symptom severity under an additive (allelic) model, we found a genotype × trauma interaction in females (P < 0.001), but not males (P > 0.1); however, there was no main effect of genotype as in our previous study. The observed interaction suggests a genetic association that increases with the degree of trauma exposure in females only. This interaction remained significant in females, but not males, after controlling for age (P < 0.001), income (P < 0.01), past substance abuse (P < 0.001), depression severity (P = 0.02), or child abuse (P < 0.0005), and all five combined (P = 0.01). No significant effects of genotype (or interactions) were found when modeling depression severity when controlling for comorbid PTSD symptom severity (P > 0.1), demonstrating the relative specificity of this variant for PTSD symptoms. A meta-analysis with the previously reported African-American samples revealed a strong association between PTSD symptom severity and the interaction between trauma and genotype in females (N = 1424, P < 0.0001).
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23505260      PMCID: PMC3738001          DOI: 10.1002/ajmg.b.32145

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  42 in total

1.  Comparison of the PTSD Symptom Scale-Interview Version and the Clinician-Administered PTSD scale.

Authors:  E B Foa; D F Tolin
Journal:  J Trauma Stress       Date:  2000-04

2.  PAC1 receptor (ADCYAP1R1) genotype is associated with dark-enhanced startle in children.

Authors:  T Jovanovic; S D Norrholm; J Davis; K B Mercer; L Almli; A Nelson; D Cross; A Smith; K J Ressler; B Bradley
Journal:  Mol Psychiatry       Date:  2012-07-10       Impact factor: 15.992

3.  Physical symptoms, posttraumatic stress disorder, and healthcare utilization of women with and without childhood physical and sexual abuse.

Authors:  M Farley; B M Patsalides
Journal:  Psychol Rep       Date:  2001-12

4.  Posttraumatic stress disorder and the incidence of nicotine, alcohol, and other drug disorders in persons who have experienced trauma.

Authors:  Naomi Breslau; Glenn C Davis; Lonni R Schultz
Journal:  Arch Gen Psychiatry       Date:  2003-03

5.  A second look at comorbidity in victims of trauma: the posttraumatic stress disorder-major depression connection.

Authors:  N Breslau; G C Davis; E L Peterson; L R Schultz
Journal:  Biol Psychiatry       Date:  2000-11-01       Impact factor: 13.382

6.  Health functioning impairments associated with posttraumatic stress disorder, anxiety disorders, and depression.

Authors:  Claudia Zayfert; Aricca R Dums; Robert J Ferguson; Mark T Hegel
Journal:  J Nerv Ment Dis       Date:  2002-04       Impact factor: 2.254

Review 7.  Posttraumatic stress disorder: the burden to the individual and to society.

Authors:  R C Kessler
Journal:  J Clin Psychiatry       Date:  2000       Impact factor: 4.384

8.  Development and validation of a brief screening version of the Childhood Trauma Questionnaire.

Authors:  David P Bernstein; Judith A Stein; Michael D Newcomb; Edward Walker; David Pogge; Taruna Ahluvalia; John Stokes; Leonard Handelsman; Martha Medrano; David Desmond; William Zule
Journal:  Child Abuse Negl       Date:  2003-02

9.  Women's treatment utilization and its relationship to childhood sexual abuse history and lifetime PTSD.

Authors:  Tracy L Simpson
Journal:  Subst Abus       Date:  2002-03       Impact factor: 3.716

10.  Genetic and environmental influences on trauma exposure and posttraumatic stress disorder symptoms: a twin study.

Authors:  Murray B Stein; Kerry L Jang; Steven Taylor; Philip A Vernon; W John Livesley
Journal:  Am J Psychiatry       Date:  2002-10       Impact factor: 18.112

View more
  48 in total

Review 1.  DNA methylation correlates of PTSD: Recent findings and technical challenges.

Authors:  Filomene G Morrison; Mark W Miller; Mark W Logue; Michele Assef; Erika J Wolf
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-11-30       Impact factor: 5.067

Review 2.  Pituitary adenylate cyclase activating polypeptide (PACAP), stress, and sex hormones.

Authors:  S Bradley King; Donna J Toufexis; Sayamwong E Hammack
Journal:  Stress       Date:  2017-06-14       Impact factor: 3.493

Review 3.  Neuroimaging genetic approaches to Posttraumatic Stress Disorder.

Authors:  Lauren A M Lebois; Jonathan D Wolff; Kerry J Ressler
Journal:  Exp Neurol       Date:  2016-04-22       Impact factor: 5.330

Review 4.  Genetic approaches for the study of PTSD: Advances and challenges.

Authors:  Sunayana B Banerjee; Filomene G Morrison; Kerry J Ressler
Journal:  Neurosci Lett       Date:  2017-02-24       Impact factor: 3.046

Review 5.  Pituitary adenylate cyclase activating polypeptide in stress-related disorders: data convergence from animal and human studies.

Authors:  Sayamwong E Hammack; Victor May
Journal:  Biol Psychiatry       Date:  2014-12-09       Impact factor: 13.382

6.  Pituitary adenylate cyclase-activating polypeptide (PACAP) in the bed nucleus of the stria terminalis (BNST) increases corticosterone in male and female rats.

Authors:  K R Lezak; E Roelke; O M Harris; I Choi; S Edwards; N Gick; G Cocchiaro; G Missig; C W Roman; K M Braas; D J Toufexis; V May; S E Hammack
Journal:  Psychoneuroendocrinology       Date:  2014-03-25       Impact factor: 4.905

7.  Stress and Bronchodilator Response in Children with Asthma.

Authors:  John M Brehm; Sima K Ramratnam; Sze Man Tse; Damien C Croteau-Chonka; Maria Pino-Yanes; Christian Rosas-Salazar; Augusto A Litonjua; Benjamin A Raby; Nadia Boutaoui; Yueh-Ying Han; Wei Chen; Erick Forno; Anna L Marsland; Nicole R Nugent; Celeste Eng; Angel Colón-Semidey; María Alvarez; Edna Acosta-Pérez; Melissa L Spear; Fernando D Martinez; Lydiana Avila; Scott T Weiss; Manuel Soto-Quiros; Carole Ober; Dan L Nicolae; Kathleen C Barnes; Robert F Lemanske; Robert C Strunk; Andrew Liu; Stephanie J London; Frank Gilliland; Patrick Sleiman; Michael March; Hakon Hakonarson; Qing Ling Duan; Jay K Kolls; Gregory K Fritz; Donglei Hu; Negar Fani; Jennifer S Stevens; Lynn M Almli; Esteban G Burchard; Jaemin Shin; Elizabeth L McQuaid; Kerry Ressler; Glorisa Canino; Juan C Celedón
Journal:  Am J Respir Crit Care Med       Date:  2015-07-01       Impact factor: 21.405

Review 8.  Genomic updates in understanding PTSD.

Authors:  Sumeet Sharma; Kerry J Ressler
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2018-11-16       Impact factor: 5.067

Review 9.  Neuroendocrine pathways underlying risk and resilience to PTSD in women.

Authors:  Meghna Ravi; Jennifer S Stevens; Vasiliki Michopoulos
Journal:  Front Neuroendocrinol       Date:  2019-09-19       Impact factor: 8.606

10.  Parabrachial nucleus (PBn) pituitary adenylate cyclase activating polypeptide (PACAP) signaling in the amygdala: implication for the sensory and behavioral effects of pain.

Authors:  Galen Missig; Carolyn W Roman; Margaret A Vizzard; Karen M Braas; Sayamwong E Hammack; Victor May
Journal:  Neuropharmacology       Date:  2014-07-03       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.